Strategies to prevent hepatitis B virus infection in China: immunization, screening, and standard medical practices
- PMID: 23524888
Strategies to prevent hepatitis B virus infection in China: immunization, screening, and standard medical practices
Abstract
China has one of the world's highest rates of hepatitis B infection. Over the past 20 years, a series of strategies have been implemented to prevent infection with the hepatitis B virus (HBV) in China. These strategies include hepatitis B (hepB) immunization for susceptible populations such as infants and young children and for high-risk populations such as health care workers and patients, premarital health care for couples of childbearing age, and standard medical practices. A series of measures implemented by the Chinese government caused the HBV infection rate in China to decrease from 9.75% in 1992 to 7.2% in 2006. However, a report on infectious diseases indicated that more than 1 million people in China were infected with hepB in 2011. There is room for improvement. The current work analyzed the current status of and challenges for strategies to prevent HBV infection in China. This work also recommends clear guidance regarding hepB immunization for parents in rural areas, more flexible premarital health care, health education for both patients and health care workers, and routine HBV screening for high-risk health care workers.
Similar articles
-
Implementing strategies for hepatitis B vaccination.Saudi J Kidney Dis Transpl. 2010 Jan;21(1):10-22. Saudi J Kidney Dis Transpl. 2010. PMID: 20061687 Review.
-
Postvaccination serologic testing results for infants aged ≤24 months exposed to hepatitis B virus at birth: United States, 2008-2011.MMWR Morb Mortal Wkly Rep. 2012 Sep 28;61:768-71. MMWR Morb Mortal Wkly Rep. 2012. PMID: 23013723
-
Progress in hepatitis B prevention through universal infant vaccination--China, 1997-2006.MMWR Morb Mortal Wkly Rep. 2007 May 11;56(18):441-5. MMWR Morb Mortal Wkly Rep. 2007. PMID: 17495790
-
Epidemiology and prevention of hepatitis B virus infection in China.J Viral Hepat. 2010 Mar;17 Suppl 1:4-9. doi: 10.1111/j.1365-2893.2010.01266.x. J Viral Hepat. 2010. PMID: 20586928 Review.
-
[Study on the risk factors of HBV infection in children under the age of 15 in Shanghai].Zhonghua Liu Xing Bing Xue Za Zhi. 2010 May;31(5):530-3. Zhonghua Liu Xing Bing Xue Za Zhi. 2010. PMID: 21163031 Chinese.
Cited by
-
Increasing Coverage of Hepatitis B Vaccination in China: A Systematic Review of Interventions and Implementation Experiences.Medicine (Baltimore). 2016 May;95(19):e3693. doi: 10.1097/MD.0000000000003693. Medicine (Baltimore). 2016. PMID: 27175710 Free PMC article.
-
Significance of incorporation of DNMT1 and HLA-DRα with TNM staging in patients with hepatocellular carcinoma after curative resection.Int J Clin Exp Pathol. 2017 Sep 1;10(9):9372-9381. eCollection 2017. Int J Clin Exp Pathol. 2017. PMID: 31966809 Free PMC article.
-
Serum Biomarkers AFP, CEA and CA19-9 Combined Detection for Early Diagnosis of Hepatocellular Carcinoma.Iran J Public Health. 2019 Feb;48(2):314-322. Iran J Public Health. 2019. PMID: 31205886 Free PMC article.
-
Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial.Trials. 2014 Nov 10;15:438. doi: 10.1186/1745-6215-15-438. Trials. 2014. PMID: 25381721 Free PMC article. Clinical Trial.
-
Factors associated with adults' perceived need to vaccinate against hepatitis B in rural China.Hum Vaccin Immunother. 2016 May 3;12(5):1149-54. doi: 10.1080/21645515.2015.1132964. Epub 2016 Apr 4. Hum Vaccin Immunother. 2016. PMID: 27042968 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous